Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensitivity and Specificity of the NOVA-DN VEP Protocol and a Novel Analysis of Optical Coherence Tomography Images for Glaucoma Diagnosis

NCT02622178 is registered in ClinicalTrials.gov with Wills Eye as lead sponsor.

NCT NCT02622178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02622178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensitivity and Specificity of the NOVA-DN VEP Protocol and a Novel Analysis of Optical Coherence Tomography Images for Glaucoma Diagnosis
Lead sponsor
Wills Eye
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2011
Completion date
December 31, 2013
Enrollment
136 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma diagnosis